ribosom
special
entiti
particip
regul
gene
express
rrna
carri
ribozym
activ
ribosom
biogenesi
overactiv
cancer
cell
although
involv
ribosom
qualiti
unknown
show
repress
express
rrna
methyltransferas
fibrillarin
fbl
bind
directli
fbl
high
level
fbl
accompani
modif
rrna
methyl
pattern
impair
translat
fidel
increas
intern
ribosom
entri
site
ire
depend
translat
initi
key
cancer
gene
fbl
overexpress
contribut
tumorigenesi
associ
poor
surviv
patient
breast
cancer
thu
act
safeguard
protein
synthesi
regul
fbl
subsequ
qualiti
intrins
activ
ribosom
recent
find
support
emerg
notion
dysregul
ribosom
biogenesi
cancer
cell
consequ
oncogenesi
repres
key
step
complex
process
barna
et
al
bywat
et
al
yoon
et
al
ribosom
biogenesi
multistag
process
involv
transcript
posttranscript
regul
stringent
qualiti
control
produc
function
ribosom
bashan
yonath
henra
et
al
ribosom
biogenesi
overactiv
cancer
cell
notabl
loss
function
rna
polymeras
pol
repressor
bywat
et
al
zhai
comai
posttranscript
step
ribosom
rna
rrna
process
determin
structur
function
matur
molecul
king
et
al
baxterroshek
et
al
puglisi
inde
rrna
ribozym
support
decod
proofread
step
catalyz
format
peptid
signific
ribosom
product
increas
cancer
cell
enhanc
product
ribosom
play
crucial
role
tumor
progress
result
show
regul
pattern
ribosom
rna
posttranscript
modif
impair
translat
fidel
increas
initi
intern
ribosom
entri
site
ire
depend
translat
demonstr
regul
biogenesi
intrins
activ
ribosom
studi
demonstr
defici
particip
translat
reprogram
cancer
cell
contribut
uncontrol
express
key
oncogen
gene
bond
translat
cech
demeshkina
et
al
rrna
subject
intens
highli
specif
chemic
modif
methyl
pseudouridyl
exact
role
modif
yet
fulli
elucid
although
appear
help
optim
complex
ribosom
architectur
requir
produc
effici
ribosom
baxterroshek
et
al
chang
posttranscript
modif
rrna
influenc
translat
fidel
ie
nonsens
suppress
amino
acid
misincorpor
mode
translat
initi
ie
cap
versu
intern
ribosom
entri
site
ire
key
cancer
gene
ruggero
basu
et
al
baxterroshek
et
al
moreov
defect
rrna
methyl
pseudouridyl
may
caus
specif
clinic
syndrom
correl
increas
incid
cancer
belin
et
al
montanaro
et
al
studi
aim
determin
whether
control
rrna
methyl
subsequ
affect
translat
regul
fbl
express
invers
associ
activ
cell
line
human
breast
cancer
sampl
fibrillarin
fbl
indispens
highli
conserv
protein
essenti
process
prerrna
newton
et
al
tollervey
et
al
eukaryot
known
methyltransferas
perform
specif
oribosemethyl
direct
larg
famili
small
transact
guid
rna
box
cd
antisens
snorna
abnorm
rrna
methyl
could
influenc
translat
control
regul
rrna
transcript
explor
whether
fbl
express
associ
activ
measur
fbl
mrna
protein
level
differ
cell
line
express
andor
activ
modul
differ
strategi
immort
human
mammari
epitheli
cell
hme
activ
impair
either
reduc
express
use
shrna
approach
inactiv
use
tt
antigen
trap
strategi
hmle
elenbaa
et
al
respons
knockdown
inactiv
signific
increas
fbl
express
mrna
protein
figur
figur
avail
onlin
expect
observ
decreas
express
encod
two
target
gene
valid
reduct
activ
cellular
model
figur
invers
correl
fbl
express
confirm
second
seri
immort
hmec
line
figur
isogen
human
colorect
cellular
model
cell
express
wildtyp
protein
cell
lack
protein
express
bunz
et
al
fbl
mrna
protein
level
increas
cell
compar
cell
figur
demonstr
increas
express
fbl
respons
inactiv
restrict
mammari
cell
line
assess
directli
impact
fbl
express
hme
cell
treat
sirna
instead
shrna
induc
transient
knockdown
express
figur
condit
increas
fbl
express
mrna
protein
level
correl
inhibit
express
figur
taken
togeth
result
exclud
possibl
chang
fbl
express
level
result
offtarget
effect
firmli
link
fbl
express
express
addit
investig
impact
activ
fbl
express
treat
hme
cell
topoisomeras
inhibitor
doxorubicin
camptothecin
promin
activ
result
show
expect
induct
respons
treatment
accompani
decreas
fbl
mrna
protein
level
figur
quantif
western
blot
demonstr
signific
associ
increas
protein
level
decreas
fbl
protein
level
figur
express
endogen
fbl
indic
cell
line
analyz
mrna
level
rtqpcr
c
e
protein
level
western
blot
b
f
graph
repres
mean
sd
least
three
experi
p
p
accord
student
test
see
also
figur
human
cancer
tumor
suppressor
gene
frequent
inactiv
mainli
mutat
olivi
et
al
determin
whether
fbl
express
associ
mutat
statu
independ
genet
variat
cell
line
analyz
fbl
express
level
panel
three
wildtyp
breast
cell
line
five
mutant
breast
cancer
cell
line
high
level
fbl
mrna
protein
significantli
associ
express
mutant
figur
result
prompt
us
investig
clinic
correl
mutat
statu
fbl
express
analyz
fbl
mrna
express
level
rtqpcr
relat
mutat
statu
cohort
randomli
select
primari
breast
tumor
tabl
consist
result
obtain
cell
line
fbl
mrna
level
significantli
higher
mutant
tumor
compar
wildtyp
tumor
figur
also
perform
retrospect
statist
analysi
gene
express
array
data
describ
miller
colleagu
miller
et
al
fbl
mrna
level
significantli
higher
mutant
tumor
n
wildtyp
tumor
n
p
test
altogeth
result
show
signific
reproduc
invers
associ
level
andor
activ
express
fbl
mrna
protein
level
suggest
repress
fbl
express
cellular
model
breast
colon
cancer
well
human
breast
tumor
repress
fbl
express
directli
bind
dna
use
matinspector
softwar
databas
two
put
respons
element
identifi
within
fbl
intron
suggest
direct
transcript
regul
fbl
express
carthariu
et
al
et
al
figur
base
predict
develop
luciferas
report
pfblluc
assay
assess
whether
regul
fbl
promot
activ
cell
cotransfect
pfblluc
plasmid
express
either
wildtyp
mutant
protein
endogen
fbl
express
analyz
hme
cell
mrna
level
rtqpcr
c
protein
level
western
blot
b
express
modul
use
sirna
b
treat
nt
mgml
doxorubicin
nm
camptothecin
c
lane
splice
togeth
discontinu
lane
blot
indic
dot
line
graph
repres
mean
sd
least
three
experi
p
p
accord
student
test
see
also
figur
detect
protein
level
figur
coexpress
wildtyp
significantli
decreas
luciferas
activ
signific
variat
luciferas
activ
observ
coexpress
mutant
similar
result
observ
coexpress
wildtyp
mutant
protein
reduc
luciferas
activ
figur
result
suggest
repress
promot
activ
intron
fbl
breast
colon
cellular
model
determin
whether
directli
bind
fbl
gene
dna
chromatin
immunoprecipit
chip
assay
perform
hmederiv
cell
figur
compar
nontreat
hme
cell
camptothecin
treatment
increas
bind
promot
intron
fbl
contrast
decreas
express
cell
associ
drastic
reduct
bind
promot
intron
fbl
compar
nontreat
hme
cell
figur
data
show
bind
fbl
intron
basal
condit
activ
altogeth
result
demonstr
fbl
target
gene
fbl
express
directli
repress
directli
repress
fbl
express
determin
whether
inactiv
alter
rrna
methyl
use
previous
describ
sitespecif
semiquantit
rtqpcrbase
method
belin
et
al
maden
analyz
chang
rrna
methyl
site
distribut
along
rrna
known
methyl
site
includ
local
within
key
function
domain
rrna
ie
decod
center
dc
rrna
peptidyl
transferas
center
ptc
helix
rrna
gener
site
significantli
frequent
methyl
hme
cell
figur
overal
increas
sitespecif
rrna
methyl
pattern
consist
find
fbl
express
level
higher
hme
cell
suggest
methyl
could
regul
sitebysit
manner
expect
metabol
label
h
uridin
l
h
methionin
show
inactiv
led
signific
increas
rrna
synthesi
figur
zhai
comai
faint
increas
global
rrna
methyl
rate
figur
show
amount
andor
activ
rrna
methyl
machineri
suffici
sustain
global
rrna
methyl
rate
follow
increas
rrna
synthesi
inactiv
addit
select
site
methyl
ensur
guid
cdbox
snorna
complex
fbl
verifi
whether
snorna
express
level
alter
cell
northern
blot
analys
reveal
modif
snorna
level
accord
level
suggest
could
also
involv
regul
cdbox
snorna
case
haca
snornp
figur
krastev
et
al
howev
correl
found
amount
snorna
level
correspond
rrna
methyl
site
figur
result
show
inactiv
result
sitespecif
modif
rrna
methyl
pattern
correl
fbl
express
chemic
modif
rrna
conserv
throughout
evolut
speci
involv
least
eukaryot
control
translat
fidel
control
translat
initi
modal
ie
capdepend
versu
iresdepend
ruggero
baxterroshek
et
al
chaudhuri
et
al
ruggero
et
al
first
analyz
two
differ
exampl
translat
fidel
nonsens
suppress
amino
acid
misincorpor
belin
et
al
bypass
prematur
stopcodon
figur
misincorpor
amino
acid
figur
significantli
increas
inhibit
inactiv
differ
cell
line
suggest
translat
alter
could
due
increas
fbl
express
level
investig
possibl
analyz
misincorpor
amino
acid
respons
knockdown
fbl
express
shown
figur
reduct
fbl
express
prevent
increas
amino
acid
misincorpor
demonstr
decreas
translat
qualiti
control
respons
inhibit
depend
fbl
overexpress
contrast
abil
ribosom
induc
frameshift
sever
acut
respiratori
syndromecoronaviru
sarscov
program
ribosom
frameshift
signal
similar
three
cell
line
figur
result
suggest
inactiv
could
decreas
translat
fidel
fbldepend
manner
b
quantif
fbl
protein
express
analyz
western
blot
graph
repres
mean
sd
least
three
experi
c
boxandwhisk
plot
fbl
mrna
express
quantif
wildtyp
n
versu
mutant
n
primari
breast
tumor
sampl
bottom
top
box
repres
th
th
percentil
respect
median
valu
visibl
line
mean
cross
box
sd
error
bar
p
valu
determin
mannwhitney
w
test
see
also
figur
tabl
determin
whether
capor
iresdepend
mode
translat
modifi
use
bicistron
vector
strategi
extens
use
identifi
vast
number
irescontain
sequenc
belin
et
al
komar
hatzogl
stage
studi
focus
analysi
due
role
tumorigenesi
possess
longest
gcrich
utr
contain
wellidentifi
ire
among
human
transcript
yet
character
giraud
et
al
pollak
et
al
use
bicistron
luciferas
assay
observ
signific
increas
global
luciferas
activ
cell
compar
cell
express
wildtyp
figur
increas
due
prefer
initi
iresdepend
translat
inde
translat
firefli
luciferas
driven
ire
significantli
increas
signific
variat
detect
renilla
luciferas
driven
capdepend
mechan
figur
similar
result
obtain
hmederiv
cell
line
figur
white
bar
figur
sc
bar
moreov
hme
hmle
cell
express
similar
level
firefli
luciferas
mrna
renilla
luciferas
mrna
independ
variat
protein
level
support
hypothesi
iresmedi
translat
regul
rather
transcript
regul
express
figur
align
two
put
respons
element
black
arrow
locat
within
intron
fbl
consensu
r
ga
w
ct
n
spacer
within
consensu
dot
box
nucleotid
region
fbl
gene
clone
pfblluc
report
vector
primer
pair
use
chip
assay
b
c
luciferas
report
assay
perform
absenc
presenc
wildtyp
wt
indic
mutant
protein
b
cell
c
firefli
luciferas
activ
normal
renilla
luciferas
activ
basic
luciferas
report
vector
fbl
sequenc
e
chip
use
antibodi
primer
pair
e
perform
nontreat
nt
nm
camptothecintr
hme
cell
cell
graph
repres
mean
sd
least
three
experi
p
p
accord
student
test
see
also
figur
evalu
whether
similar
regul
exist
human
cell
line
explor
ire
activ
breast
cell
line
express
wildtyp
mutant
protein
figur
activ
level
ire
significantli
higher
mutant
cell
express
high
level
fbl
compar
wildtyp
cell
express
low
level
fbl
thu
translat
initi
mediat
ire
higher
breast
cell
line
inactiv
instead
wildtyp
confirm
ire
activ
modul
rrna
methyl
analyz
ire
activ
use
fblsirna
knockdown
approach
reduc
fbl
protein
level
figur
shown
figur
reduct
fbl
express
significantli
decreas
iresdepend
translat
initi
hme
hmle
cell
result
demonstr
effici
iresdepend
translat
initi
modul
rrna
methyl
modul
fbl
express
determin
whether
translat
control
mrna
observ
recombin
express
vector
also
occur
endogen
mrna
compar
distribut
mrna
within
polysom
fraction
hme
cell
polysom
fraction
correspond
mrna
bound
one
ribosom
therefor
contain
activ
translat
mrna
shown
figur
signific
polysom
enrich
mrna
observ
compar
hme
cell
addit
signific
increas
protein
level
observ
hmle
cell
compar
hme
cell
independ
variat
mrna
level
figur
investig
whether
translat
control
restrict
mrna
analyz
translat
control
sever
known
cellular
viral
mrna
contain
iress
includ
myc
vegfa
play
key
role
oncogenesi
dang
turner
grose
carmeliet
jain
encephalomyocard
viru
bicistron
luciferas
assay
mrna
polysom
profil
assay
show
increas
translat
effici
mrna
inactiv
cell
compar
wildtyp
cell
figur
altogeth
result
show
inactiv
impact
translat
control
sever
gene
involv
tumorigenesi
deregul
fbl
express
six
independ
stabl
clone
deriv
cell
overexpress
either
fblgfp
protein
gfp
protein
develop
figur
determin
effect
fbl
overexpress
sever
characterist
cancer
cell
cell
prolifer
stabl
clone
first
monitor
hr
index
cell
prolifer
calcul
slope
growth
curv
figur
cell
overexpress
fblgfp
exhibit
signific
increas
prolifer
rate
compar
gfp
control
cell
determin
whether
fblinduc
cell
prolifer
mediat
whose
translat
increas
fbloverexpress
cell
prolifer
two
clone
monitor
respons
tyrosin
kinas
activ
inhibitor
figur
mulvihil
et
al
inhibit
pathway
activ
abolish
differ
prolifer
rate
clone
suggest
pathway
activ
requir
cell
fblinduc
cell
prolifer
anchorageindepend
cell
prolifer
investig
use
soft
agar
assay
compar
gfp
control
clone
overexpress
fblgfp
form
significantli
coloni
figur
final
effect
fbl
overexpress
cell
growth
respons
doxorubicin
treatment
investig
figur
significantli
higher
concentr
doxorubicin
requir
reach
inhibitori
effect
fblgfp
cell
compar
gfp
control
cell
mean
halfmaxim
inhibitori
concentr
ic
mm
versu
mm
respect
altogeth
data
show
fbl
overexpress
promot
cell
prolifer
anchoragedepend
independ
manner
protect
breast
cancer
cell
doxorubicin
moreov
fblinduc
cell
prolifer
requir
pathway
support
notion
fbl
overexpress
directli
contribut
tumorigenesi
alter
translat
control
key
cancer
gene
investig
whether
level
fbl
mrna
tumor
associ
prognosi
analyz
relapsefre
surviv
breast
cancerspecif
surviv
patient
breast
cancer
regard
fbl
express
high
express
fbl
mrna
significantli
associ
poor
relapsefre
surviv
rate
poor
breast
cancerspecif
surviv
rate
figur
also
perform
retrospect
statist
analys
publish
gene
express
array
data
rffi
et
al
sabati
et
al
weigelt
et
al
investig
confirm
high
level
fbl
mrna
associ
poor
breast
cancerspecif
surviv
relapsefre
surviv
rate
figur
howev
high
level
fbl
express
associ
mutat
mutat
known
associ
poor
diseasefre
overal
surviv
rate
olivi
et
al
multivari
analysi
conduct
adjust
possibl
confound
variabl
analysi
includ
number
invad
lymph
node
histolog
grade
estrogen
progesteron
receptor
statu
statu
mutat
statu
fbl
mrna
level
best
model
associ
poor
surviv
contain
two
independ
marker
progesteron
receptorneg
statu
high
fbl
express
tabl
analys
show
fbl
express
associ
poor
surviv
independ
commonli
use
clinic
marker
clearli
establish
ribosom
synthesi
increas
cancer
due
overexpress
oncogen
inactiv
tumor
suppressor
gene
lead
sustain
increas
rna
pol
activ
bywat
et
al
moreov
studi
perform
differ
anim
cellular
model
variou
eukaryot
organ
shown
heterogen
ribosom
composit
due
regul
posttranscript
modif
ribosom
protein
rrna
like
common
mechan
xue
barna
xue
barna
made
detail
contribut
extend
concept
special
ribosom
eukaryot
highlight
adapt
capabl
ribosom
control
cell
fate
select
protein
synthesi
moreov
well
demonstr
within
ribosom
rrna
catalyz
control
protein
synthesi
ribozym
activ
could
fine
optim
rrna
methyl
pseudouridyl
baxterroshek
et
al
belin
et
al
studi
show
alter
ribosom
biogenesi
translat
control
cancer
cell
typic
polysom
profil
fraction
postmitochondri
supernat
hme
cell
sucros
gradient
shown
upper
distribut
mrna
within
polysom
determin
rtqpcr
lower
e
f
endogen
express
mrna
e
black
bar
protein
level
e
white
bar
f
analyz
hme
hmle
cell
graph
repres
mean
sd
least
three
experi
p
p
p
accord
student
test
see
also
figur
regul
translat
modul
fibrillarin
could
contribut
gene
express
dysregul
cancer
develop
ruggero
demonstr
role
control
rrna
methyl
pattern
directli
regul
fbl
express
level
lead
synthesi
modifi
cancer
ribosom
notion
fbl
gene
support
genomewid
analys
chipseq
assay
show
bind
fbl
gene
encod
databas
nikulenkov
et
al
transcriptom
analysi
show
invers
express
fbl
respons
inactiv
sirna
activ
doxorubicin
sever
cell
line
troester
et
al
respons
element
also
identifi
first
intron
approxim
target
gene
associ
gene
repress
includ
gene
involv
ribosom
biogenesi
snornp
chaperon
gene
menendez
et
al
krastev
et
al
found
methyl
pattern
rrna
vari
site
consist
publish
data
baxterroshek
et
al
belin
et
al
basu
et
al
suggest
rrna
modif
pattern
modul
sitebysit
manner
data
show
inactiv
suffici
alter
rrna
methyl
pattern
addit
regul
fbl
express
role
optim
rrna
function
qualiti
reinforc
observ
level
cdbox
snorna
modul
accord
statu
involv
assembl
process
major
famili
snornp
haca
box
krastev
et
al
deciph
mechan
inactiv
alter
sitespecif
rrna
methyl
pattern
fbl
induct
requir
biochem
structur
studi
dedic
understand
format
dynam
activ
rrna
methyl
complex
howev
hypothes
improp
induct
fbl
express
observ
cancer
cell
lead
alter
coordin
prerrna
product
rrna
methyl
enzymat
machineri
today
sever
piec
data
includ
indic
modul
methyl
rrna
site
suffici
affect
translat
regul
process
could
alter
cellular
behavior
without
induc
lethal
phenotyp
king
et
al
baudinbaillieu
et
al
higanakamin
et
al
inde
deplet
methyl
sever
rrna
methyl
site
yeast
human
cell
associ
decreas
translat
fidel
increas
nonsens
suppress
frameshift
amino
acid
misincorpor
baxterroshek
et
al
baudinbaillieu
et
al
moreov
modul
rrna
methyl
deplet
hela
cell
modifi
control
translat
initi
ire
basu
et
al
modif
rrna
methyl
pattern
breast
cancer
cell
exhibit
induc
aggress
phenotyp
also
associ
alter
ire
activ
key
factor
vascular
endotheli
growth
factor
vegf
belin
et
al
present
studi
demonstr
repress
fbl
express
accompani
increas
iresdepend
translat
initi
affect
cellular
well
viral
irescontain
mrna
data
consist
previou
report
show
mrna
translat
inhibit
wherea
mrna
ire
aberrantli
activ
transform
cell
inactiv
gali
et
al
remain
systemat
explor
effect
methyl
site
individu
pattern
intrins
activ
ribosom
modul
intrins
activ
ribosom
alter
rrna
methyl
may
involv
structur
chang
ribosom
inhibit
rrna
methyl
alter
ire
translat
initi
impair
associ
subunit
basu
et
al
moreov
structur
biochem
studi
show
ribos
methyl
modifi
conform
state
rna
backbon
stabil
rna
loop
influenc
overal
structur
modifi
rna
region
ribos
methyl
help
maintain
tertiari
structur
rrna
potenti
rrnamrna
rrnatrna
rrnaprotein
interact
blanchard
puglisi
liang
et
al
consist
sever
rrna
region
promot
structur
modif
viral
ire
bound
subunit
spahn
et
al
effici
translat
mrna
result
ire
directli
contact
rrna
domain
shinedalgarnolik
interact
meng
et
al
data
support
notion
rrna
methyl
could
particip
translat
control
regul
ire
translat
initi
clinic
analysi
show
high
level
fbl
primari
breast
tumor
associ
poor
surviv
independ
biolog
marker
elev
express
level
fbl
previous
report
primari
metastat
prostat
cancer
compar
normal
prostat
epithelium
squamou
cell
cervic
carcinoma
compar
normal
cervix
sampl
choi
et
al
koh
et
al
su
et
al
furthermor
shown
direct
contribut
fbl
overexpress
tumorigenesi
mainten
progress
cancer
phenotyp
induc
fblmediat
enhanc
translat
may
involv
sever
key
cancer
protein
whose
synthesi
depend
upon
irescontain
mrna
shown
e
impact
fbl
overexpress
drug
respons
investig
determin
ic
doxorubicin
use
mt
assay
error
bar
repres
sd
p
valu
determin
mannwhitney
w
test
f
g
kaplanmei
analysi
relapsefre
surviv
rate
event
relaps
f
breast
cancerspecif
surviv
rate
event
death
relat
breast
cancer
diseas
g
accord
fbl
mrna
level
primari
breast
tumor
sampl
data
dichotom
upper
quartil
valu
high
low
express
group
see
also
figur
tabl
protein
may
includ
involv
tumor
progress
cell
surviv
respons
chemotherapi
pollak
et
al
cmyc
exhibit
pleiotrop
prooncogen
function
dang
involv
epithelialmesenchym
transit
sakuma
et
al
vegfa
involv
tumor
angiogenesi
carmeliet
jain
thu
high
level
fbl
observ
human
sampl
could
role
tumor
progress
could
affect
clinic
outcom
patient
alter
translat
regul
result
allow
us
propos
model
regul
ribosom
product
rate
also
structur
function
intrins
activ
figur
model
alter
patholog
cell
result
product
ribosom
decreas
translat
fidel
increas
translat
irescontain
mrna
select
thu
ribosom
alter
could
part
respons
translat
instabl
cancer
cell
contribut
express
continu
cell
express
function
top
neg
regul
rna
pol
activ
control
ribosom
quantiti
fbl
express
level
control
ribosom
qualiti
regul
would
aim
coordin
methyl
ribosom
rate
ribosom
product
accord
cell
need
qualitycontrol
ribosom
allow
high
translat
fidel
togeth
correct
control
balanc
capand
iresdepend
initi
translat
cell
express
mutant
nonfunct
bottom
loss
repress
rna
pol
activ
lead
increas
rrna
synthesi
parallel
inactiv
lead
increas
fbl
express
level
result
modif
rrna
methyl
pattern
ribosom
modifi
rrna
methyl
translat
mrna
lower
fidel
bypass
stop
codon
amino
acid
misincorpor
like
initi
translat
ire
mrna
code
prooncogen
antiapoptot
surviv
protein
grow
class
translat
regul
cancerpromot
gene
ruggero
final
detail
descript
rrna
chemic
modif
pattern
cancer
cell
occur
part
regul
ribosom
biogenesi
enzymat
machineri
increas
knowledg
ribosom
structur
atom
level
anger
et
al
open
possibl
target
cancer
ribosom
develop
anticanc
molecul
use
strategi
similar
use
develop
antibiot
specif
target
prokaryot
ribosom
yonath
cell
cultur
transfect
luciferas
assay
cell
maintain
cultur
follow
atcc
recommend
sirna
plasmid
belin
et
al
transfect
use
lipofectamin
invitrogen
cell
treat
mgml
doxorubicin
nm
camptothecin
sigma
luciferas
activ
measur
use
dual
luciferas
report
assay
kit
promega
anchoragedepend
cell
prolifer
analyz
use
realtim
monitor
cell
prolifer
assay
base
variat
electr
imped
use
xcellig
rtca
system
acea
bioscienc
hr
nontreat
cell
presenc
mm
selleckchen
anchorageindepend
cell
prolifer
analyz
soft
agar
assay
ic
valu
doxorubicin
determin
mt
assay
promega
protein
extract
western
blot
perform
describ
belin
et
al
use
follow
antibodi
antifbl
abcam
santa
cruz
antibactin
sigma
bethyl
laboratori
santa
cruz
santa
cruz
chip
assay
chromatin
prepar
formaldehyd
fix
cell
sonic
immunoprecipit
perform
bp
dna
fragment
use
antibodi
immunoprecipit
dna
quantifi
qpcr
use
sybr
green
technolog
total
mrna
polysom
mrna
rrna
methyl
quantif
total
rna
rna
issu
cytosol
polysom
fraction
extract
purifi
use
either
trizol
reagent
invitrogen
tripur
isol
reagent
roch
cytosol
ribosom
obtain
postmitochondri
fraction
polysom
ribosom
separ
postmitochondri
fraction
sucros
gradient
ultracentrifig
total
cytosol
polysom
mrna
level
quantifi
rtqpcr
use
mmlv
sybr
green
technolog
describ
ghayad
et
al
sitespecif
rrna
methyl
quantifi
use
rtqpcr
base
method
reli
inhibit
revers
transcript
reaction
ribos
methyl
low
dntp
concentr
detect
total
rrna
intern
refer
revers
transcript
high
dntp
concentr
belin
et
al
rt
product
quantifi
qpcr
breast
tumor
sampl
fbl
mrna
express
analyz
cohort
primari
breast
tumor
collect
ninewel
hospit
white
women
receiv
neoadjuv
treatment
prior
surgeri
taysid
tissu
bank
dunde
tabl
inform
consent
obtain
patient
ethic
approv
receiv
taysid
tissu
bank
rec
refer
deleg
author
local
research
ethic
committe
relapsefre
surviv
calcul
among
breast
cancer
patient
date
diagnosi
date
relaps
event
relaps
breast
cancerspecif
surviv
calcul
date
diagnosi
date
breast
cancer
specif
death
event
death
relat
breast
cancer
diseas
character
classic
molecular
marker
histolog
grade
invad
lymph
node
mutat
well
estrogen
progesteron
statu
previous
determin
report
bourdon
et
al
statist
analys
perform
use
statgraph
plu
softwar
statgraph
centurion
logrank
test
univari
analysi
kaplanmei
plot
cox
proport
hazard
model
multivari
analysi
perform
use
spss
softwar
p
valu
consid
statist
signific
graph
present
mean
standard
variat
least
three
independ
experi
student
test
perform
experiment
data
experiment
procedur
detail
supplement
experiment
procedur
supplement
inform
includ
supplement
experiment
procedur
seven
figur
two
tabl
found
articl
onlin
http
